Structure Therapeutics (GPCR) Enterprise Value: 491.70M

Structure Therapeutics, Inc. (GPCR)

25.58 -0.09 (-0.35%) USD | NASDAQ | Oct 09, 14:56

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2023. Start Trial.

Date	Value
October 08, 2026	491.70M
October 07, 2026	563.63M
October 06, 2026	619.89M
October 05, 2026	628.44M
October 02, 2026	634.14M
October 01, 2026	727.43M
September 30, 2026	890.52M
September 29, 2026	991.65M
September 28, 2026	1.161B
September 25, 2026	1.222B
September 24, 2026	1.229B
September 23, 2026	1.224B
September 22, 2026	1.292B
September 21, 2026	1.285B
September 18, 2026	1.156B
September 17, 2026	1.163B
September 16, 2026	1.192B
September 15, 2026	1.437B
September 14, 2026	1.401B
September 11, 2026	1.417B
September 10, 2026	1.480B
September 09, 2026	1.600B
September 08, 2026	1.539B
September 04, 2026	2.035B
September 03, 2026	2.035B

Date	Value
September 02, 2026	2.068B
September 01, 2026	2.020B
August 31, 2026	1.933B
August 28, 2026	2.037B
August 27, 2026	2.169B
August 26, 2026	2.178B
August 25, 2026	2.219B
August 24, 2026	2.154B
August 21, 2026	2.160B
August 20, 2026	2.261B
August 19, 2026	2.519B
August 18, 2026	2.476B
August 17, 2026	2.492B
August 14, 2026	2.546B
August 13, 2026	2.559B
August 12, 2026	2.503B
August 11, 2026	2.376B
August 10, 2026	2.495B
August 07, 2026	2.448B
August 06, 2026	2.411B
August 05, 2026	2.262B
August 04, 2026	2.199B
August 03, 2026	2.108B
July 31, 2026	2.085B
July 30, 2026	2.187B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks